It's another wild twist in the story of Galapagos, a company that has been around for more than 25 years but has yet to get a ...

Meanwhile, Bayer CEO Bill Anderson said Donald Trump’s Most Favored Nations policy could present an opportunity for European ...

The third cycle of the drug price negotiations will involve drugs under Medicare Part B. New prices are set to take effect in ...

The commitment is part of Roche’s recently announced $50 billion investment in the U.S., but a company spokesperson said that ...

The Most Favored Nations directive would allow drugmakers to directly sell their products to patients at a lower cost, ...